Mirtazapine Tablet, Film Coated
Product Images NDC 0615-8268
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 0615-8268). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ncs Healthcare Of Ky, Inc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel-mirtazapine 15mg Tab Bingo Label (Mirtazapine Tabs 8268 8269 Aurolife 2)
This is a package of Mirtazapine Tablets USP 15 mg manufactured by Aurolife for Aurobindo. The package contains 16 tablets and is intended for institutional use only. Dosage information should be obtained from the package insert or label. The tablets should be stored at 20°- 25°C (68°-77° F) in a tightly closed light-resistant container. The lot number for this package is 8268 and the expiration date is not available.*
Principal Display Panel-mirtazapine 30mg Tab Bingo Label (Mirtazapine Tabs 8268 8269 Aurolife 3)
This appears to be a package label for Mirtazapine tablets, with the strength of 30mg. The manufacturer is listed as Aurolife for Aurobindo and the National Drug Code is 13107-003-34. The lot number mentioned is 8269 and the expiration date is also listed. Dosage information is available on the package insert or label. The package should be stored at controlled room temperature in a light-resistant container. The package seems to be for institutional use only.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.